PAPER Zhu N, Santos-Santos M, Illán-Gala I, Montal V, Estellés T, Barroeta I, Altuna M, Arranz J, Muñoz L, Belbin O, Sala I, Sánchez-Saudinós MB, Subirana A, Videla L, Pegueroles J, Blesa R, Clarimón J, Carmona-Iragui M, Fortea J, Lleó A, Alcolea D
SEARCH RESULTS
270363 RESULTS
PAPER Huang P, Zhang LY, Tan YY, Chen SD
Correction: Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
Transl Neurodegener. 2023 May 12;12(1):23. PubMed.PAPER Huang Z, Jordan JD, Zhang Q
Early life adversity as a risk factor for cognitive impairment and Alzheimer's disease.
Transl Neurodegener. 2023 May 12;12(1):25. PubMed.PAPER LaBarbera KM, Sheline YI, Izzo NJ, Yuede CM, Waybright L, Yurko R, Edwards HM, Gardiner WD, Blennow K, Zetterberg H, Börjesson-Hanson A, Morgan R, Davis CS, Guttendorf RJ, Schneider LS, DeKosky S, LeVine H 3rd, Grundman M, Caggiano AO, Cirrito JR, Catalano SM, Hamby ME
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.
Transl Neurodegener. 2023 May 12;12(1):24. PubMed.PAPER Olson KE, Abdelmoaty MM, Namminga KL, Lu Y, Obaro H, Santamaria P, Mosley RL, Gendelman HE
An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers.
Transl Neurodegener. 2023 May 22;12(1):26. PubMed.PAPER Shin JH, Kim H, Kim YK, Yoon EJ, Nam H, Jeon B, Lee JY
Longitudinal evolution of cortical thickness signature reflecting Lewy body dementia in isolated REM sleep behavior disorder: a prospective cohort study.
Transl Neurodegener. 2023 May 22;12(1):27. PubMed.PAPER Lo CH, Zeng J
Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases.
Transl Neurodegener. 2023 Jun 8;12(1):29. PubMed.PAPER Drobny A, Boros FA, Balta D, Prieto Huarcaya S, Caylioglu D, Qazi N, Vandrey J, Schneider Y, Dobert JP, Pitcairn C, Mazzulli JR, Zunke F
Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models.
Transl Neurodegener. 2023 Jun 13;12(1):31. PubMed.PAPER Nango H, Tsuruta K, Miyagishi H, Aono Y, Saigusa T, Kosuge Y
Update on the pathological roles of prostaglandin E2 in neurodegeneration in amyotrophic lateral sclerosis.
Transl Neurodegener. 2023 Jun 19;12(1):32. PubMed.PAPER Xu L, Liu R, Qin Y, Wang T
Brain metabolism in Alzheimer's disease: biological mechanisms of exercise.
Transl Neurodegener. 2023 Jun 26;12(1):33. PubMed.PAPER Lu J, Ma X, Zhang H, Xiao Z, Li M, Wu J, Ju Z, Chen L, Zheng L, Ge J, Liang X, Bao W, Wu P, Ding D, Yen TC, Guan Y, Zuo C, Zhao Q, Shanghai Memory Study (SMS)
Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints.
Transl Neurodegener. 2023 Jun 29;12(1):34. PubMed.PAPER D'Andrea C, Cazzaniga FA, Bistaffa E, Barucci A, de Angelis M, Banchelli M, Farnesi E, Polykretis P, Marzi C, Indaco A, Tiraboschi P, Giaccone G, Matteini P, Moda F
Impact of seed amplification assay and surface-enhanced Raman spectroscopy combined approach on the clinical diagnosis of Alzheimer's disease.
Transl Neurodegener. 2023 Jul 12;12(1):35. PubMed.PAPER Dovonou A, Bolduc C, Soto Linan V, Gora C, Peralta Iii MR, Lévesque M
Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.
Transl Neurodegener. 2023 Jul 19;12(1):36. PubMed.PAPER Catumbela CS, Giridharan VV, Barichello T, Morales R
Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview.
Transl Neurodegener. 2023 Jul 26;12(1):37. PubMed.PAPER Pan F, Lu Y, Huang Q, Xie F, Yang J, Guo Q
The potential impact of clinical factors on blood-based biomarkers for Alzheimer's disease.
Transl Neurodegener. 2023 Aug 18;12(1):39. PubMed.Current Filters
- TYPE: Paper x